CN111471667B - 壳聚糖酶Csn-PT及其应用 - Google Patents
壳聚糖酶Csn-PT及其应用 Download PDFInfo
- Publication number
- CN111471667B CN111471667B CN202010491045.9A CN202010491045A CN111471667B CN 111471667 B CN111471667 B CN 111471667B CN 202010491045 A CN202010491045 A CN 202010491045A CN 111471667 B CN111471667 B CN 111471667B
- Authority
- CN
- China
- Prior art keywords
- chitosanase
- csn
- chitosan
- enzyme
- lys
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 108010089807 chitosanase Proteins 0.000 title claims abstract description 47
- 229920001661 Chitosan Polymers 0.000 claims abstract description 24
- 230000000593 degrading effect Effects 0.000 claims abstract description 11
- 125000003275 alpha amino acid group Chemical group 0.000 claims abstract 2
- 238000000034 method Methods 0.000 claims description 8
- RQFQJYYMBWVMQG-IXDPLRRUSA-N chitotriose Chemical compound O[C@@H]1[C@@H](N)[C@H](O)O[C@H](CO)[C@H]1O[C@H]1[C@H](N)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O2)N)[C@@H](CO)O1 RQFQJYYMBWVMQG-IXDPLRRUSA-N 0.000 claims description 7
- 230000015556 catabolic process Effects 0.000 claims description 4
- 238000006731 degradation reaction Methods 0.000 claims description 4
- MSWZFWKMSRAUBD-IVMDWMLBSA-N 2-amino-2-deoxy-D-glucopyranose Chemical compound N[C@H]1C(O)O[C@H](CO)[C@@H](O)[C@@H]1O MSWZFWKMSRAUBD-IVMDWMLBSA-N 0.000 claims 1
- FZHXIRIBWMQPQF-UHFFFAOYSA-N Glc-NH2 Natural products O=CC(N)C(O)C(O)C(O)CO FZHXIRIBWMQPQF-UHFFFAOYSA-N 0.000 claims 1
- MSWZFWKMSRAUBD-UHFFFAOYSA-N beta-D-galactosamine Natural products NC1C(O)OC(CO)C(O)C1O MSWZFWKMSRAUBD-UHFFFAOYSA-N 0.000 claims 1
- 150000002772 monosaccharides Chemical class 0.000 claims 1
- 108090000790 Enzymes Proteins 0.000 abstract description 32
- 102000004190 Enzymes Human genes 0.000 abstract description 31
- 108090000623 proteins and genes Proteins 0.000 abstract description 14
- 230000000694 effects Effects 0.000 abstract description 11
- 238000002360 preparation method Methods 0.000 abstract description 11
- 238000006243 chemical reaction Methods 0.000 abstract description 10
- 230000003197 catalytic effect Effects 0.000 abstract description 5
- 239000002773 nucleotide Substances 0.000 abstract description 2
- 125000003729 nucleotide group Chemical group 0.000 abstract description 2
- 229940088598 enzyme Drugs 0.000 description 28
- RAXXELZNTBOGNW-UHFFFAOYSA-N imidazole Natural products C1=CNC=N1 RAXXELZNTBOGNW-UHFFFAOYSA-N 0.000 description 12
- 239000000243 solution Substances 0.000 description 9
- 239000000047 product Substances 0.000 description 8
- 241000588724 Escherichia coli Species 0.000 description 6
- 239000012634 fragment Substances 0.000 description 5
- 241000894006 Bacteria Species 0.000 description 4
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 4
- 239000007853 buffer solution Substances 0.000 description 4
- 102000004169 proteins and genes Human genes 0.000 description 4
- QKNYBSVHEMOAJP-UHFFFAOYSA-N 2-amino-2-(hydroxymethyl)propane-1,3-diol;hydron;chloride Chemical compound Cl.OCC(N)(CO)CO QKNYBSVHEMOAJP-UHFFFAOYSA-N 0.000 description 3
- 150000001413 amino acids Chemical group 0.000 description 3
- 239000003153 chemical reaction reagent Substances 0.000 description 3
- 239000000413 hydrolysate Substances 0.000 description 3
- OOYGSFOGFJDDHP-KMCOLRRFSA-N kanamycin A sulfate Chemical compound OS(O)(=O)=O.O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CN)O[C@@H]1O[C@H]1[C@H](O)[C@@H](O[C@@H]2[C@@H]([C@@H](N)[C@H](O)[C@@H](CO)O2)O)[C@H](N)C[C@@H]1N OOYGSFOGFJDDHP-KMCOLRRFSA-N 0.000 description 3
- 229960002064 kanamycin sulfate Drugs 0.000 description 3
- 239000013612 plasmid Substances 0.000 description 3
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 3
- GIQCDTKOIPUDSG-GARJFASQSA-N Asn-Lys-Pro Chemical compound C1C[C@@H](N(C1)C(=O)[C@H](CCCCN)NC(=O)[C@H](CC(=O)N)N)C(=O)O GIQCDTKOIPUDSG-GARJFASQSA-N 0.000 description 2
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 2
- YWAQATDNEKZFFK-BYPYZUCNSA-N Gly-Gly-Ser Chemical compound NCC(=O)NCC(=O)N[C@@H](CO)C(O)=O YWAQATDNEKZFFK-BYPYZUCNSA-N 0.000 description 2
- INCJJHQRZGQLFC-KBPBESRZSA-N Leu-Phe-Gly Chemical compound [H]N[C@@H](CC(C)C)C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)NCC(O)=O INCJJHQRZGQLFC-KBPBESRZSA-N 0.000 description 2
- 108010079364 N-glycylalanine Proteins 0.000 description 2
- 230000008859 change Effects 0.000 description 2
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 2
- 238000010367 cloning Methods 0.000 description 2
- 238000010276 construction Methods 0.000 description 2
- 230000007547 defect Effects 0.000 description 2
- 238000001514 detection method Methods 0.000 description 2
- 238000010586 diagram Methods 0.000 description 2
- 230000002255 enzymatic effect Effects 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- 108010078144 glutaminyl-glycine Proteins 0.000 description 2
- VPZXBVLAVMBEQI-UHFFFAOYSA-N glycyl-DL-alpha-alanine Natural products OC(=O)C(C)NC(=O)CN VPZXBVLAVMBEQI-UHFFFAOYSA-N 0.000 description 2
- 108010015792 glycyllysine Proteins 0.000 description 2
- 239000001963 growth medium Substances 0.000 description 2
- 238000009776 industrial production Methods 0.000 description 2
- 229930027917 kanamycin Natural products 0.000 description 2
- 229960000318 kanamycin Drugs 0.000 description 2
- SBUJHOSQTJFQJX-NOAMYHISSA-N kanamycin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CN)O[C@@H]1O[C@H]1[C@H](O)[C@@H](O[C@@H]2[C@@H]([C@@H](N)[C@H](O)[C@@H](CO)O2)O)[C@H](N)C[C@@H]1N SBUJHOSQTJFQJX-NOAMYHISSA-N 0.000 description 2
- 229930182823 kanamycin A Natural products 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 229920001542 oligosaccharide Polymers 0.000 description 2
- 150000002482 oligosaccharides Chemical class 0.000 description 2
- 238000000053 physical method Methods 0.000 description 2
- BDERNNFJNOPAEC-UHFFFAOYSA-N propan-1-ol Chemical compound CCCO BDERNNFJNOPAEC-UHFFFAOYSA-N 0.000 description 2
- 230000009467 reduction Effects 0.000 description 2
- 239000011780 sodium chloride Substances 0.000 description 2
- 238000002415 sodium dodecyl sulfate polyacrylamide gel electrophoresis Methods 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 108010061238 threonyl-glycine Proteins 0.000 description 2
- 238000011144 upstream manufacturing Methods 0.000 description 2
- YYSWCHMLFJLLBJ-ZLUOBGJFSA-N Ala-Ala-Ser Chemical compound C[C@H](N)C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(O)=O YYSWCHMLFJLLBJ-ZLUOBGJFSA-N 0.000 description 1
- QDRGPQWIVZNJQD-CIUDSAMLSA-N Ala-Arg-Gln Chemical compound [H]N[C@@H](C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCC(N)=O)C(O)=O QDRGPQWIVZNJQD-CIUDSAMLSA-N 0.000 description 1
- UCIYCBSJBQGDGM-LPEHRKFASA-N Ala-Arg-Pro Chemical compound C[C@@H](C(=O)N[C@@H](CCCN=C(N)N)C(=O)N1CCC[C@@H]1C(=O)O)N UCIYCBSJBQGDGM-LPEHRKFASA-N 0.000 description 1
- TTXMOJWKNRJWQJ-FXQIFTODSA-N Ala-Arg-Ser Chemical compound OC[C@@H](C(O)=O)NC(=O)[C@@H](NC(=O)[C@@H](N)C)CCCN=C(N)N TTXMOJWKNRJWQJ-FXQIFTODSA-N 0.000 description 1
- MDNAVFBZPROEHO-UHFFFAOYSA-N Ala-Lys-Val Natural products CC(C)C(C(O)=O)NC(=O)C(NC(=O)C(C)N)CCCCN MDNAVFBZPROEHO-UHFFFAOYSA-N 0.000 description 1
- DCVYRWFAMZFSDA-ZLUOBGJFSA-N Ala-Ser-Ala Chemical compound [H]N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(O)=O DCVYRWFAMZFSDA-ZLUOBGJFSA-N 0.000 description 1
- OEVCHROQUIVQFZ-YTLHQDLWSA-N Ala-Thr-Ala Chemical compound C[C@H](N)C(=O)N[C@@H]([C@H](O)C)C(=O)N[C@@H](C)C(O)=O OEVCHROQUIVQFZ-YTLHQDLWSA-N 0.000 description 1
- KUFVXLQLDHJVOG-SHGPDSBTSA-N Ala-Thr-Thr Chemical compound C[C@H]([C@@H](C(=O)N[C@@H]([C@@H](C)O)C(=O)O)NC(=O)[C@H](C)N)O KUFVXLQLDHJVOG-SHGPDSBTSA-N 0.000 description 1
- VHUUQVKOLVNVRT-UHFFFAOYSA-N Ammonium hydroxide Chemical compound [NH4+].[OH-] VHUUQVKOLVNVRT-UHFFFAOYSA-N 0.000 description 1
- HAVKMRGWNXMCDR-STQMWFEESA-N Arg-Gly-Phe Chemical compound [H]N[C@@H](CCCNC(N)=N)C(=O)NCC(=O)N[C@@H](CC1=CC=CC=C1)C(O)=O HAVKMRGWNXMCDR-STQMWFEESA-N 0.000 description 1
- ZZZWQALDSQQBEW-STQMWFEESA-N Arg-Gly-Tyr Chemical compound [H]N[C@@H](CCCNC(N)=N)C(=O)NCC(=O)N[C@@H](CC1=CC=C(O)C=C1)C(O)=O ZZZWQALDSQQBEW-STQMWFEESA-N 0.000 description 1
- YVTHEZNOKSAWRW-DCAQKATOSA-N Arg-Lys-Ala Chemical compound [H]N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(O)=O YVTHEZNOKSAWRW-DCAQKATOSA-N 0.000 description 1
- RYQSYXFGFOTJDJ-RHYQMDGZSA-N Arg-Thr-Leu Chemical compound [H]N[C@@H](CCCNC(N)=N)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(O)=O RYQSYXFGFOTJDJ-RHYQMDGZSA-N 0.000 description 1
- LVHMEJJWEXBMKK-GMOBBJLQSA-N Asn-Ile-Met Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CCSC)C(=O)O)NC(=O)[C@H](CC(=O)N)N LVHMEJJWEXBMKK-GMOBBJLQSA-N 0.000 description 1
- YVXRYLVELQYAEQ-SRVKXCTJSA-N Asn-Leu-Lys Chemical compound CC(C)C[C@@H](C(=O)N[C@@H](CCCCN)C(=O)O)NC(=O)[C@H](CC(=O)N)N YVXRYLVELQYAEQ-SRVKXCTJSA-N 0.000 description 1
- NTWOPSIUJBMNRI-KKUMJFAQSA-N Asn-Lys-Tyr Chemical compound NC(=O)C[C@H](N)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(O)=O)CC1=CC=C(O)C=C1 NTWOPSIUJBMNRI-KKUMJFAQSA-N 0.000 description 1
- YXVAESUIQFDBHN-SRVKXCTJSA-N Asn-Phe-Ser Chemical compound [H]N[C@@H](CC(N)=O)C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](CO)C(O)=O YXVAESUIQFDBHN-SRVKXCTJSA-N 0.000 description 1
- FMNBYVSGRCXWEK-FOHZUACHSA-N Asn-Thr-Gly Chemical compound [H]N[C@@H](CC(N)=O)C(=O)N[C@@H]([C@@H](C)O)C(=O)NCC(O)=O FMNBYVSGRCXWEK-FOHZUACHSA-N 0.000 description 1
- JZLFYAAGGYMRIK-BYULHYEWSA-N Asn-Val-Asp Chemical compound [H]N[C@@H](CC(N)=O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(O)=O)C(O)=O JZLFYAAGGYMRIK-BYULHYEWSA-N 0.000 description 1
- HBUJSDCLZCXXCW-YDHLFZDLSA-N Asn-Val-Tyr Chemical compound NC(=O)C[C@H](N)C(=O)N[C@@H](C(C)C)C(=O)N[C@H](C(O)=O)CC1=CC=C(O)C=C1 HBUJSDCLZCXXCW-YDHLFZDLSA-N 0.000 description 1
- KRXIWXCXOARFNT-ZLUOBGJFSA-N Asp-Ala-Ala Chemical compound OC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@@H](N)CC(O)=O KRXIWXCXOARFNT-ZLUOBGJFSA-N 0.000 description 1
- MNQMTYSEKZHIDF-GCJQMDKQSA-N Asp-Thr-Ala Chemical compound [H]N[C@@H](CC(O)=O)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C)C(O)=O MNQMTYSEKZHIDF-GCJQMDKQSA-N 0.000 description 1
- XAPPCWUWHNWCPQ-PBCZWWQYSA-N Asp-Thr-His Chemical compound N[C@@H](CC(=O)O)C(=O)N[C@@H]([C@H](O)C)C(=O)N[C@@H](CC1=CNC=N1)C(=O)O XAPPCWUWHNWCPQ-PBCZWWQYSA-N 0.000 description 1
- JSNWZMFSLIWAHS-HJGDQZAQSA-N Asp-Thr-Leu Chemical compound C[C@H]([C@@H](C(=O)N[C@@H](CC(C)C)C(=O)O)NC(=O)[C@H](CC(=O)O)N)O JSNWZMFSLIWAHS-HJGDQZAQSA-N 0.000 description 1
- MRYDJCIIVRXVGG-QEJZJMRPSA-N Asp-Trp-Glu Chemical compound [H]N[C@@H](CC(O)=O)C(=O)N[C@@H](CC1=CNC2=C1C=CC=C2)C(=O)N[C@@H](CCC(O)=O)C(O)=O MRYDJCIIVRXVGG-QEJZJMRPSA-N 0.000 description 1
- 238000009010 Bradford assay Methods 0.000 description 1
- 108020004705 Codon Proteins 0.000 description 1
- 108700010070 Codon Usage Proteins 0.000 description 1
- VBPGTULCFGKGTF-ACZMJKKPSA-N Cys-Glu-Asp Chemical compound [H]N[C@@H](CS)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(O)=O)C(O)=O VBPGTULCFGKGTF-ACZMJKKPSA-N 0.000 description 1
- DZSICRGTVPDCRN-YUMQZZPRSA-N Cys-Gly-Lys Chemical compound C(CCN)C[C@@H](C(=O)O)NC(=O)CNC(=O)[C@H](CS)N DZSICRGTVPDCRN-YUMQZZPRSA-N 0.000 description 1
- OUBUHIODTNUUTC-WDCWCFNPSA-N Gln-Thr-Lys Chemical compound C[C@H]([C@@H](C(=O)N[C@@H](CCCCN)C(=O)O)NC(=O)[C@H](CCC(=O)N)N)O OUBUHIODTNUUTC-WDCWCFNPSA-N 0.000 description 1
- RNPGPFAVRLERPP-QEJZJMRPSA-N Gln-Trp-Asn Chemical compound [H]N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC1=CNC2=C1C=CC=C2)C(=O)N[C@@H](CC(N)=O)C(O)=O RNPGPFAVRLERPP-QEJZJMRPSA-N 0.000 description 1
- CLROYXHHUZELFX-FXQIFTODSA-N Glu-Gln-Asp Chemical compound [H]N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(O)=O)C(O)=O CLROYXHHUZELFX-FXQIFTODSA-N 0.000 description 1
- ZWABFSSWTSAMQN-KBIXCLLPSA-N Glu-Ile-Ala Chemical compound [H]N[C@@H](CCC(O)=O)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](C)C(O)=O ZWABFSSWTSAMQN-KBIXCLLPSA-N 0.000 description 1
- VSVZIEVNUYDAFR-YUMQZZPRSA-N Gly-Ala-Leu Chemical compound CC(C)C[C@@H](C(O)=O)NC(=O)[C@H](C)NC(=O)CN VSVZIEVNUYDAFR-YUMQZZPRSA-N 0.000 description 1
- QSDKBRMVXSWAQE-BFHQHQDPSA-N Gly-Ala-Thr Chemical compound C[C@@H](O)[C@@H](C(O)=O)NC(=O)[C@H](C)NC(=O)CN QSDKBRMVXSWAQE-BFHQHQDPSA-N 0.000 description 1
- UHPAZODVFFYEEL-QWRGUYRKSA-N Gly-Leu-Leu Chemical compound CC(C)C[C@@H](C(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)CN UHPAZODVFFYEEL-QWRGUYRKSA-N 0.000 description 1
- PCPOYRCAHPJXII-UWVGGRQHSA-N Gly-Lys-Met Chemical compound [H]NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCSC)C(O)=O PCPOYRCAHPJXII-UWVGGRQHSA-N 0.000 description 1
- VNNRLUNBJSWZPF-ZKWXMUAHSA-N Gly-Ser-Ile Chemical compound [H]NCC(=O)N[C@@H](CO)C(=O)N[C@@H]([C@@H](C)CC)C(O)=O VNNRLUNBJSWZPF-ZKWXMUAHSA-N 0.000 description 1
- WCORRBXVISTKQL-WHFBIAKZSA-N Gly-Ser-Ser Chemical compound NCC(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(O)=O WCORRBXVISTKQL-WHFBIAKZSA-N 0.000 description 1
- VCDNHBNNPCDBKV-DLOVCJGASA-N His-Ala-Lys Chemical compound C[C@@H](C(=O)N[C@@H](CCCCN)C(=O)O)NC(=O)[C@H](CC1=CN=CN1)N VCDNHBNNPCDBKV-DLOVCJGASA-N 0.000 description 1
- 108090000604 Hydrolases Proteins 0.000 description 1
- 102000004157 Hydrolases Human genes 0.000 description 1
- CWJQMCPYXNVMBS-STECZYCISA-N Ile-Arg-Tyr Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](CC1=CC=C(C=C1)O)C(=O)O)N CWJQMCPYXNVMBS-STECZYCISA-N 0.000 description 1
- UAVQIQOOBXFKRC-BYULHYEWSA-N Ile-Asn-Gly Chemical compound CC[C@H](C)[C@H](N)C(=O)N[C@@H](CC(N)=O)C(=O)NCC(O)=O UAVQIQOOBXFKRC-BYULHYEWSA-N 0.000 description 1
- JXMSHKFPDIUYGS-SIUGBPQLSA-N Ile-Glu-Tyr Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC1=CC=C(C=C1)O)C(=O)O)N JXMSHKFPDIUYGS-SIUGBPQLSA-N 0.000 description 1
- GVNNAHIRSDRIII-AJNGGQMLSA-N Ile-Lys-Lys Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)O)N GVNNAHIRSDRIII-AJNGGQMLSA-N 0.000 description 1
- YCKPUHHMCFSUMD-IUKAMOBKSA-N Ile-Thr-Asp Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(=O)O)C(=O)O)N YCKPUHHMCFSUMD-IUKAMOBKSA-N 0.000 description 1
- 239000012880 LB liquid culture medium Substances 0.000 description 1
- HBJZFCIVFIBNSV-DCAQKATOSA-N Leu-Arg-Asn Chemical compound CC(C)C[C@H](N)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](CC(N)=O)C(O)=O HBJZFCIVFIBNSV-DCAQKATOSA-N 0.000 description 1
- RFUBXQQFJFGJFV-GUBZILKMSA-N Leu-Asn-Gln Chemical compound [H]N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(O)=O RFUBXQQFJFGJFV-GUBZILKMSA-N 0.000 description 1
- USTCFDAQCLDPBD-XIRDDKMYSA-N Leu-Asn-Trp Chemical compound CC(C)C[C@@H](C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](CC1=CNC2=CC=CC=C21)C(=O)O)N USTCFDAQCLDPBD-XIRDDKMYSA-N 0.000 description 1
- ULXYQAJWJGLCNR-YUMQZZPRSA-N Leu-Asp-Gly Chemical compound CC(C)C[C@H](N)C(=O)N[C@@H](CC(O)=O)C(=O)NCC(O)=O ULXYQAJWJGLCNR-YUMQZZPRSA-N 0.000 description 1
- DLCXCECTCPKKCD-GUBZILKMSA-N Leu-Gln-Asn Chemical compound [H]N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(O)=O DLCXCECTCPKKCD-GUBZILKMSA-N 0.000 description 1
- GLBNEGIOFRVRHO-JYJNAYRXSA-N Leu-Gln-Phe Chemical compound [H]N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC1=CC=CC=C1)C(O)=O GLBNEGIOFRVRHO-JYJNAYRXSA-N 0.000 description 1
- HPBCTWSUJOGJSH-MNXVOIDGSA-N Leu-Glu-Ile Chemical compound [H]N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H]([C@@H](C)CC)C(O)=O HPBCTWSUJOGJSH-MNXVOIDGSA-N 0.000 description 1
- 102000004882 Lipase Human genes 0.000 description 1
- 239000004367 Lipase Substances 0.000 description 1
- 108090001060 Lipase Proteins 0.000 description 1
- YNNPKXBBRZVIRX-IHRRRGAJSA-N Lys-Arg-Leu Chemical compound [H]N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(C)C)C(O)=O YNNPKXBBRZVIRX-IHRRRGAJSA-N 0.000 description 1
- DNEJSAIMVANNPA-DCAQKATOSA-N Lys-Asn-Arg Chemical compound [H]N[C@@H](CCCCN)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCNC(N)=N)C(O)=O DNEJSAIMVANNPA-DCAQKATOSA-N 0.000 description 1
- YVSHZSUKQHNDHD-KKUMJFAQSA-N Lys-Asn-Phe Chemical compound C1=CC=C(C=C1)C[C@@H](C(=O)O)NC(=O)[C@H](CC(=O)N)NC(=O)[C@H](CCCCN)N YVSHZSUKQHNDHD-KKUMJFAQSA-N 0.000 description 1
- NRQRKMYZONPCTM-CIUDSAMLSA-N Lys-Asp-Ser Chemical compound [H]N[C@@H](CCCCN)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CO)C(O)=O NRQRKMYZONPCTM-CIUDSAMLSA-N 0.000 description 1
- ITWQLSZTLBKWJM-YUMQZZPRSA-N Lys-Gly-Ala Chemical compound OC(=O)[C@H](C)NC(=O)CNC(=O)[C@@H](N)CCCCN ITWQLSZTLBKWJM-YUMQZZPRSA-N 0.000 description 1
- WVJNGSFKBKOKRV-AJNGGQMLSA-N Lys-Leu-Ile Chemical compound [H]N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H]([C@@H](C)CC)C(O)=O WVJNGSFKBKOKRV-AJNGGQMLSA-N 0.000 description 1
- GOVDTWNJCBRRBJ-DCAQKATOSA-N Lys-Met-Asn Chemical compound CSCC[C@@H](C(=O)N[C@@H](CC(=O)N)C(=O)O)NC(=O)[C@H](CCCCN)N GOVDTWNJCBRRBJ-DCAQKATOSA-N 0.000 description 1
- TXTZMVNJIRZABH-ULQDDVLXSA-N Lys-Val-Phe Chemical compound NCCCC[C@H](N)C(=O)N[C@@H](C(C)C)C(=O)N[C@H](C(O)=O)CC1=CC=CC=C1 TXTZMVNJIRZABH-ULQDDVLXSA-N 0.000 description 1
- RIPJMCFGQHGHNP-RHYQMDGZSA-N Lys-Val-Thr Chemical compound C[C@H]([C@@H](C(=O)O)NC(=O)[C@H](C(C)C)NC(=O)[C@H](CCCCN)N)O RIPJMCFGQHGHNP-RHYQMDGZSA-N 0.000 description 1
- PCTFVQATEGYHJU-FXQIFTODSA-N Met-Ser-Asn Chemical compound [H]N[C@@H](CCSC)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(N)=O)C(O)=O PCTFVQATEGYHJU-FXQIFTODSA-N 0.000 description 1
- JZXKNNOWPBVZEV-XIRDDKMYSA-N Met-Trp-Glu Chemical compound CSCC[C@@H](C(=O)N[C@@H](CC1=CNC2=CC=CC=C21)C(=O)N[C@@H](CCC(=O)O)C(=O)O)N JZXKNNOWPBVZEV-XIRDDKMYSA-N 0.000 description 1
- WUGMRIBZSVSJNP-UHFFFAOYSA-N N-L-alanyl-L-tryptophan Natural products C1=CC=C2C(CC(NC(=O)C(N)C)C(O)=O)=CNC2=C1 WUGMRIBZSVSJNP-UHFFFAOYSA-N 0.000 description 1
- XZFYRXDAULDNFX-UHFFFAOYSA-N N-L-cysteinyl-L-phenylalanine Natural products SCC(N)C(=O)NC(C(O)=O)CC1=CC=CC=C1 XZFYRXDAULDNFX-UHFFFAOYSA-N 0.000 description 1
- KZNQNBZMBZJQJO-UHFFFAOYSA-N N-glycyl-L-proline Natural products NCC(=O)N1CCCC1C(O)=O KZNQNBZMBZJQJO-UHFFFAOYSA-N 0.000 description 1
- 238000012408 PCR amplification Methods 0.000 description 1
- 241000040600 Paenibacillus tyrfis Species 0.000 description 1
- 108091005804 Peptidases Proteins 0.000 description 1
- IDUCUXTUHHIQIP-SOUVJXGZSA-N Phe-Gln-Pro Chemical compound C1C[C@@H](N(C1)C(=O)[C@H](CCC(=O)N)NC(=O)[C@H](CC2=CC=CC=C2)N)C(=O)O IDUCUXTUHHIQIP-SOUVJXGZSA-N 0.000 description 1
- TXKWKTWYTIAZSV-KKUMJFAQSA-N Phe-Leu-Cys Chemical compound CC(C)C[C@@H](C(=O)N[C@@H](CS)C(=O)O)NC(=O)[C@H](CC1=CC=CC=C1)N TXKWKTWYTIAZSV-KKUMJFAQSA-N 0.000 description 1
- YTILBRIUASDGBL-BZSNNMDCSA-N Phe-Leu-Leu Chemical compound CC(C)C[C@@H](C(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CC1=CC=CC=C1 YTILBRIUASDGBL-BZSNNMDCSA-N 0.000 description 1
- DNAXXTQSTKOHFO-QEJZJMRPSA-N Phe-Lys-Ala Chemical compound OC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CC1=CC=CC=C1 DNAXXTQSTKOHFO-QEJZJMRPSA-N 0.000 description 1
- KLYYKKGCPOGDPE-OEAJRASXSA-N Phe-Thr-Leu Chemical compound [H]N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(O)=O KLYYKKGCPOGDPE-OEAJRASXSA-N 0.000 description 1
- XROLYVMNVIKVEM-BQBZGAKWSA-N Pro-Asn-Gly Chemical compound [H]N1CCC[C@H]1C(=O)N[C@@H](CC(N)=O)C(=O)NCC(O)=O XROLYVMNVIKVEM-BQBZGAKWSA-N 0.000 description 1
- ILMLVTGTUJPQFP-FXQIFTODSA-N Pro-Asp-Asp Chemical compound [H]N1CCC[C@H]1C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC(O)=O)C(O)=O ILMLVTGTUJPQFP-FXQIFTODSA-N 0.000 description 1
- SGCZFWSQERRKBD-BQBZGAKWSA-N Pro-Asp-Gly Chemical compound OC(=O)CNC(=O)[C@H](CC(O)=O)NC(=O)[C@@H]1CCCN1 SGCZFWSQERRKBD-BQBZGAKWSA-N 0.000 description 1
- NXEYSLRNNPWCRN-SRVKXCTJSA-N Pro-Glu-Leu Chemical compound [H]N1CCC[C@H]1C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(C)C)C(O)=O NXEYSLRNNPWCRN-SRVKXCTJSA-N 0.000 description 1
- UEHYFUCOGHWASA-HJGDQZAQSA-N Pro-Glu-Thr Chemical compound C[C@@H](O)[C@@H](C(O)=O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@@H]1CCCN1 UEHYFUCOGHWASA-HJGDQZAQSA-N 0.000 description 1
- 239000004365 Protease Substances 0.000 description 1
- 102100037486 Reverse transcriptase/ribonuclease H Human genes 0.000 description 1
- LVVBAKCGXXUHFO-ZLUOBGJFSA-N Ser-Ala-Asp Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(O)=O)C(O)=O LVVBAKCGXXUHFO-ZLUOBGJFSA-N 0.000 description 1
- ZXLUWXWISXIFIX-ACZMJKKPSA-N Ser-Asn-Glu Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCC(O)=O)C(O)=O ZXLUWXWISXIFIX-ACZMJKKPSA-N 0.000 description 1
- DKKGAAJTDKHWOD-BIIVOSGPSA-N Ser-Asn-Pro Chemical compound C1C[C@@H](N(C1)C(=O)[C@H](CC(=O)N)NC(=O)[C@H](CO)N)C(=O)O DKKGAAJTDKHWOD-BIIVOSGPSA-N 0.000 description 1
- GZSZPKSBVAOGIE-CIUDSAMLSA-N Ser-Lys-Ala Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(O)=O GZSZPKSBVAOGIE-CIUDSAMLSA-N 0.000 description 1
- FPCGZYMRFFIYIH-CIUDSAMLSA-N Ser-Lys-Ser Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(O)=O FPCGZYMRFFIYIH-CIUDSAMLSA-N 0.000 description 1
- QMCDMHWAKMUGJE-IHRRRGAJSA-N Ser-Phe-Val Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](C(C)C)C(O)=O QMCDMHWAKMUGJE-IHRRRGAJSA-N 0.000 description 1
- URPSJRMWHQTARR-MBLNEYKQSA-N Thr-Ile-Gly Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)N[C@@H]([C@@H](C)CC)C(=O)NCC(O)=O URPSJRMWHQTARR-MBLNEYKQSA-N 0.000 description 1
- HOVLHEKTGVIKAP-WDCWCFNPSA-N Thr-Leu-Gln Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(N)=O)C(O)=O HOVLHEKTGVIKAP-WDCWCFNPSA-N 0.000 description 1
- BDYBHQWMHYDRKJ-UNQGMJICSA-N Thr-Phe-Met Chemical compound C[C@H]([C@@H](C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](CCSC)C(=O)O)N)O BDYBHQWMHYDRKJ-UNQGMJICSA-N 0.000 description 1
- MEBDIIKMUUNBSB-RPTUDFQQSA-N Thr-Phe-Tyr Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(O)=O MEBDIIKMUUNBSB-RPTUDFQQSA-N 0.000 description 1
- GAYLGYUVTDMLKC-UWJYBYFXSA-N Tyr-Asp-Ala Chemical compound OC(=O)[C@H](C)NC(=O)[C@H](CC(O)=O)NC(=O)[C@@H](N)CC1=CC=C(O)C=C1 GAYLGYUVTDMLKC-UWJYBYFXSA-N 0.000 description 1
- NMKJPMCEKQHRPD-IRXDYDNUSA-N Tyr-Gly-Tyr Chemical compound C([C@H](N)C(=O)NCC(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(O)=O)C1=CC=C(O)C=C1 NMKJPMCEKQHRPD-IRXDYDNUSA-N 0.000 description 1
- AZSHAZJLOZQYAY-FXQIFTODSA-N Val-Ala-Ser Chemical compound CC(C)[C@H](N)C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(O)=O AZSHAZJLOZQYAY-FXQIFTODSA-N 0.000 description 1
- ZSZFTYVFQLUWBF-QXEWZRGKSA-N Val-Asp-Met Chemical compound CC(C)[C@@H](C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CCSC)C(=O)O)N ZSZFTYVFQLUWBF-QXEWZRGKSA-N 0.000 description 1
- OVLIFGQSBSNGHY-KKHAAJSZSA-N Val-Asp-Thr Chemical compound C[C@H]([C@@H](C(=O)O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](C(C)C)N)O OVLIFGQSBSNGHY-KKHAAJSZSA-N 0.000 description 1
- VLDMQVZZWDOKQF-AUTRQRHGSA-N Val-Glu-Gln Chemical compound CC(C)[C@@H](C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCC(=O)N)C(=O)O)N VLDMQVZZWDOKQF-AUTRQRHGSA-N 0.000 description 1
- WBAJDGWKRIHOAC-GVXVVHGQSA-N Val-Lys-Gln Chemical compound [H]N[C@@H](C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(N)=O)C(O)=O WBAJDGWKRIHOAC-GVXVVHGQSA-N 0.000 description 1
- WUFHZIRMAZZWRS-OSUNSFLBSA-N Val-Thr-Ile Chemical compound CC[C@H](C)[C@@H](C(=O)O)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](C(C)C)N WUFHZIRMAZZWRS-OSUNSFLBSA-N 0.000 description 1
- 238000002835 absorbance Methods 0.000 description 1
- 238000001042 affinity chromatography Methods 0.000 description 1
- 238000000246 agarose gel electrophoresis Methods 0.000 description 1
- 108010070783 alanyltyrosine Proteins 0.000 description 1
- 235000011114 ammonium hydroxide Nutrition 0.000 description 1
- 238000000137 annealing Methods 0.000 description 1
- 230000003064 anti-oxidating effect Effects 0.000 description 1
- 230000000259 anti-tumor effect Effects 0.000 description 1
- 108010043240 arginyl-leucyl-glycine Proteins 0.000 description 1
- 206010003246 arthritis Diseases 0.000 description 1
- 108010040443 aspartyl-aspartic acid Proteins 0.000 description 1
- 108010038633 aspartylglutamate Proteins 0.000 description 1
- 108010047857 aspartylglycine Proteins 0.000 description 1
- 230000036772 blood pressure Effects 0.000 description 1
- 238000009835 boiling Methods 0.000 description 1
- 239000000872 buffer Substances 0.000 description 1
- 238000006555 catalytic reaction Methods 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 235000012000 cholesterol Nutrition 0.000 description 1
- 239000013599 cloning vector Substances 0.000 description 1
- 239000007857 degradation product Substances 0.000 description 1
- 238000004925 denaturation Methods 0.000 description 1
- 230000036425 denaturation Effects 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 229940079919 digestives enzyme preparation Drugs 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 238000001962 electrophoresis Methods 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 238000003912 environmental pollution Methods 0.000 description 1
- 238000006911 enzymatic reaction Methods 0.000 description 1
- 239000013604 expression vector Substances 0.000 description 1
- 238000000855 fermentation Methods 0.000 description 1
- 230000004151 fermentation Effects 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 238000004108 freeze drying Methods 0.000 description 1
- 108010079547 glutamylmethionine Proteins 0.000 description 1
- 108010066198 glycyl-leucyl-phenylalanine Proteins 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 125000005842 heteroatom Chemical group 0.000 description 1
- 108010092114 histidylphenylalanine Proteins 0.000 description 1
- 108010085325 histidylproline Proteins 0.000 description 1
- 230000007062 hydrolysis Effects 0.000 description 1
- 238000006460 hydrolysis reaction Methods 0.000 description 1
- 238000011534 incubation Methods 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 239000002054 inoculum Substances 0.000 description 1
- 108010034529 leucyl-lysine Proteins 0.000 description 1
- 235000019421 lipase Nutrition 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 108010025153 lysyl-alanyl-alanine Proteins 0.000 description 1
- 108010038320 lysylphenylalanine Proteins 0.000 description 1
- 239000002609 medium Substances 0.000 description 1
- 108010005942 methionylglycine Proteins 0.000 description 1
- FEMOMIGRRWSMCU-UHFFFAOYSA-N ninhydrin Chemical compound C1=CC=C2C(=O)C(O)(O)C(=O)C2=C1 FEMOMIGRRWSMCU-UHFFFAOYSA-N 0.000 description 1
- 238000005457 optimization Methods 0.000 description 1
- 230000001766 physiological effect Effects 0.000 description 1
- 238000006116 polymerization reaction Methods 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 238000012257 pre-denaturation Methods 0.000 description 1
- 238000004321 preservation Methods 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 108010031719 prolyl-serine Proteins 0.000 description 1
- 239000012474 protein marker Substances 0.000 description 1
- 238000012163 sequencing technique Methods 0.000 description 1
- 108010026333 seryl-proline Proteins 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 238000012289 standard assay Methods 0.000 description 1
- 239000008223 sterile water Substances 0.000 description 1
- 239000006228 supernatant Substances 0.000 description 1
- 108010003137 tyrosyltyrosine Proteins 0.000 description 1
- 238000012795 verification Methods 0.000 description 1
Images
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
- C12N9/24—Hydrolases (3) acting on glycosyl compounds (3.2)
- C12N9/2402—Hydrolases (3) acting on glycosyl compounds (3.2) hydrolysing O- and S- glycosyl compounds (3.2.1)
- C12N9/2405—Glucanases
- C12N9/2434—Glucanases acting on beta-1,4-glucosidic bonds
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/70—Vectors or expression systems specially adapted for E. coli
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P19/00—Preparation of compounds containing saccharide radicals
- C12P19/14—Preparation of compounds containing saccharide radicals produced by the action of a carbohydrase (EC 3.2.x), e.g. by alpha-amylase, e.g. by cellulase, hemicellulase
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P19/00—Preparation of compounds containing saccharide radicals
- C12P19/26—Preparation of nitrogen-containing carbohydrates
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y302/00—Hydrolases acting on glycosyl compounds, i.e. glycosylases (3.2)
- C12Y302/01—Glycosidases, i.e. enzymes hydrolysing O- and S-glycosyl compounds (3.2.1)
- C12Y302/01132—Chitosanase (3.2.1.132)
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Genetics & Genomics (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- Biomedical Technology (AREA)
- Molecular Biology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Biophysics (AREA)
- Plant Pathology (AREA)
- Physics & Mathematics (AREA)
- Medicinal Chemistry (AREA)
- Enzymes And Modification Thereof (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Abstract
本发明公开了一种壳聚糖酶Csn‑PT,其氨基酸序列如SEQ ID NO.1所示。本发明还公开了编码该壳聚糖酶Csn‑PT的基因,其核苷酸序列如SEQ ID NO.2所示。所述壳聚糖酶Csn‑PT在降解壳聚糖中的应用,在制备降解壳聚糖的酶制剂中的应用。本发明的壳聚糖酶Csn‑PT,用于降解壳聚糖,其最适pH为8,最适反应温度为50℃,比酶活可达10163.826U/mg具有高催化活性,相较于已报道的壳聚糖酶,在催化活性和效率方面具有明显的优势。
Description
技术领域
本发明涉及壳聚糖酶Csn-PT,及其在降解壳聚糖中的应用,属于功能酶技术领域。
背景技术
壳寡糖是壳聚糖降解的产物,聚合度(DP)一般在2~10之间,其分子质量低,水溶性好,具有许多生理活性,如抑菌性、抗氧化、抗肿瘤、降胆固醇、降血压、防感染以及控制关节炎等,这使得壳寡糖在医药、保健品、食品、农业等领域有了更大的应用价值。
目前,壳寡糖的制备方法主要有化学法、物理法、生物酶法。化学法、物理法制备壳寡糖存在工艺条件难控制、环境污染大、寡糖产率低等缺点。使用非专一性酶如脂肪酶、蛋白酶等酶解制备壳寡糖时,会出现水解到一定程度时加大酶量也难以提高水解程度的情况,而且水解产物较复杂难以分离。使用专一性的壳聚糖酶(EC:3.2.1.132)制备寡糖的方法具有反应条件温和、反应过程容易控制且产物纯度较高等优点。但野生型菌株产酶水平低,难以满足工业生产和应用的要求,可采用异源表达提高产酶水平,来制备酶制剂,用于工业化生产。
发明内容
针对上述现有技术,本发明提供了一种高催化活性的生成GlcN-(GlcN)6的新型壳聚糖酶——壳聚糖酶Csn-PT,以及其在降解壳聚糖中的应用,从而弥补现有技术的不足。
本发明是通过以下技术方案实现的:
壳聚糖酶Csn-PT,其氨基酸序列如SEQ ID NO.1所示。
SEQ ID NO.1:
MSNARPSKSQTKFLLAFLCFTLVASLFGATALFQPSKAAAASPDDNFSPETLQFLRNNTGLDGEQWNNIMKLINKPEQDDLNWIEYYGYCEDITDERGYTIGLFGATTGGSRDTHPDGPELFKAYDAAKGASNPSADGALKRLGINGKMNGSILEIKDSEKVFCGKIKKLQNDAAWRKAMWETFYNVYIRYSVEQARQRGFASAVTIGSFVDTALNQGATGGSNTLQGLLARSGSSSNEKTFMKNFHAKRTLVVDTNKYNKPPNGKNRVKQWDTLVDMGKMNLKNVDSEIAKVTDWEMK。
一种编码上述壳聚糖酶Csn-PT的基因,其核苷酸序列如SEQ ID NO.2所示。
SEQ ID NO.2:
5’-ATGAGCAATGCCCGCCCGAGCAAAAGCCAGACCAAATTTCTGCTGGCCTTTCTGTGTTTTACCCTGGTGGCCAGCCTGTTTGGCGCAACCGCCCTGTTTCAGCCGAGTAAAGCAGCAGCAGCAAGCCCGGATGATAATTTTAGTCCGGAAACCCTGCAGTTTCTGCGTAATAATACCGGTCTGGATGGCGAACAGTGGAATAATATTATGAAACTGATCAACAAGCCGGAACAGGATGATCTGAATTGGATTGAATATTATGGCTATTGCGAAGATATCACCGATGAACGTGGCTATACCATTGGTCTGTTTGGTGCAACCACCGGCGGCAGCCGTGATACCCATCCGGATGGTCCGGAACTGTTTAAAGCATACGATGCAGCCAAAGGTGCCAGCAATCCGAGCGCCGATGGTGCCCTGAAACGCCTGGGTATTAATGGTAAAATGAATGGCAGCATTCTGGAAATTAAGGATAGCGAAAAAGTTTTCTGTGGCAAAATTAAGAAGCTGCAGAATGATGCAGCCTGGCGTAAAGCAATGTGGGAAACCTTTTATAATGTTTATATCCGCTACAGCGTTGAACAGGCACGCCAGCGCGGTTTTGCAAGCGCCGTGACCATTGGTAGTTTTGTTGATACCGCCCTGAATCAGGGCGCCACCGGTGGCAGTAATACCCTGCAGGGTCTGCTGGCCCGCAGCGGTAGCAGTAGTAATGAAAAAACCTTTATGAAGAACTTCCACGCCAAACGTACCCTGGTGGTTGATACCAATAAGTATAATAAGCCGCCGAATGGTAAAAATCGCGTTAAACAGTGGGATACCCTGGTTGATATGGGTAAAATGAACCTGAAAAATGTTGATAGTGAGATTGCAAAAGTGACCGATTGGGAAATGAAA-3’。
上述壳聚糖酶Csn-PT在降解壳聚糖中的应用。
上述壳聚糖酶Csn-PT在制备降解壳聚糖的酶制剂中的应用。
一种降解壳聚糖的方法,采用上述氨基酸序列如SEQ ID NO.1所示的壳聚糖酶Csn-PT降解壳聚糖,生成GlcN-(GlcN)6,主要产物为壳单糖(DP1)到壳三糖(DP3),优选的降解条件为:温度50℃,pH 8。
一种酶制剂,包含有上述壳聚糖酶Csn-PT。该酶制剂在降解壳聚糖中的应用。
一种重组工程菌,其基因组中插入有上述编码壳聚糖酶Csn-PT的基因,能表达壳聚糖酶Csn-PT。该重组工程菌在制备壳聚糖酶Csn-PT中的应用。
本发明的壳聚糖酶Csn-PT,属于GH46家族,能够降解壳聚糖产生GlcN-(GlcN)6,酶解主要产物为壳单糖(DP1)到壳三糖(DP3),具有良好的生物催化效率,在50℃时其比酶活为10163.826U/mg,具有高催化活性,可高效降解壳聚糖。利用本发明的壳聚糖酶Csn-PT制备的酶制剂,具有活性好、效率高、纯度高、产量高、稳定性好等优点,具有良好的工业化应用潜质。相比较于现有的壳聚糖酶(如CN108330119A、CN102816751A中提到的壳聚糖酶),本发明的壳聚糖酶在催化活性和效率方面具有明显的优势。
本发明使用的各种术语和短语具有本领域技术人员公知的一般含义。
附图说明
图1:本发明的壳聚糖酶纯化后的纯酶SDS-PAGE电泳图,其中,M为标准蛋白Marker;1为粗酶蛋白;2为纯化后的壳聚糖酶蛋白。
图2:温度变化对相对酶活的影响示意图。
图3:本发明的壳聚糖酶,pH变化对相对酶活的影响示意图。
图4:本发明的壳聚糖酶酶解产物的TLC图。
具体实施方式
下面结合实施例对本发明作进一步的说明。然而,本发明的范围并不限于下述实施例。本领域的专业人员能够理解,在不背离本发明的精神和范围的前提下,可以对本发明进行各种变化和修饰。
下述实施例中所涉及的仪器、试剂、材料等,若无特别说明,均为现有技术中已有的常规仪器、试剂、材料等,可通过正规商业途径获得。下述实施例中所涉及的实验方法,检测方法等,若无特别说明,均为现有技术中已有的常规实验方法,检测方法等。
实施例1 壳聚糖酶基因Csn-PT的克隆
本发明的壳聚糖酶Csn-PT的产酶基因为人工合成序列。发明人挖掘到保藏于海洋微生物菌种保藏管理中心(Marine Culture Collection of China,MCCC)保藏编号MCCC:1K01247的泰氏芽孢杆菌Paenibacillus tyrfis的壳聚糖酶片段,发明人将该基因序列根据宿主大肠杆菌的密码子偏好性,进行了密码子优化,用于在大肠杆菌中进行高效表达。本发明的壳聚糖酶Csn-PT基因包含有897个碱基序列,如SEQ ID NO.2所示,编码299个氨基酸序列,如SEQ ID NO.1所示。根据进化树比对,发现该壳聚糖酶属于多糖水解酶第46家族(GH-46)。
以合成的片段为模板,在壳聚糖酶基因的上、下游设计用于无缝连接的引物,进行PCR扩增Csn-PT基因片段。
引物的序列如下所示:
上游引物:5’-CGAGTGCGGCCGCAAGCTTTTTCATTTCCCAATCGGTCAC-3’,如SEQ ID NO.3所示;
下游引物:5’-CAAATGGGTCGCGGATCCTGAGCAATGCCCGCC-3’,如SEQ ID NO.4所示。
PCR反应体系为:2×PCR Buffer 25μl,dNTP 10μl,引物各1.5μl,模板1μl,KODFx酶1μl,无菌水10μl,总体系50ul。
PCR的反应条件为:94℃预变性5min,95℃变性20s,60℃退火30s,72℃延伸60s,反应30个循环,72℃后延伸10min。
琼脂糖凝胶电泳后回收900Kb的PCR产物片段。
实施例2 含壳聚糖酶基因的表达载体构建
基因片段与pET-28a克隆载体采用无缝克隆技术进行连接,将连接产物转入E.coli DH5α感受态细胞,涂布于含有50μg/m L卡那霉素的(LB)培养基固体平板上。37℃温箱中培养12-16小时后,挑取单克隆至含有50μg/m L卡那霉素LB液体培养基,转速220rpm的37℃摇床培养过夜,阳性验证后测序,并命名为pET28a-Csn-PT。
实施例3 含壳聚糖酶基因的重组质粒及工程菌的构建
提取测序正确的重组质粒,并转化至宿主E.coli BL21感受态细胞中,构建好的工程菌在硫酸卡那霉素抗性平板上长出。
实施例4 利用大肠杆菌工程菌制备重组壳聚糖酶
挑取大肠杆菌重组菌株接种在5ml含有硫酸卡那霉素的LB液体培养基中,37℃,220rpm培养12小时后按1%的接种量接入含有硫酸卡那霉的ZYP-5052培养基,20℃,200rpm培养48h,自诱导表达壳聚糖酶。
4℃,8000g离心10分钟,收集菌体,细胞重悬于50mM pH 8.0的Tirs-HCl缓冲液中,超声破碎30min后12000g离心15min,上清液即为粗酶液。粗酶液使用Ni-NTA柱进行亲和层析纯化,使用10mM咪唑溶液(500mM NaCl,50mM Tris-HCl)平衡柱子,然后用30mM咪唑溶液(500mM NaCl,50mM Tris-HCl)洗脱结合力弱的杂蛋白,40mM咪唑溶液洗脱目的蛋白,将得到的溶液进行SDS-PAGE检测(图1),使用Bradford法测定蛋白浓度。
实施例5 重组壳聚糖酶比酶活测定
壳聚糖酶Csn-PT活性的标准测定方法为:10μL酶液加入800μL pH 8的Tris-HCl和190ul的2%的胶体壳聚糖,在50℃下反应15min,取200ul加入300μL的DNS试剂沸水浴10min进行显色,在OD540下检测其吸光度。酶活力定义为在标准条件下每min产生1μM还原糖所需要的酶量。经测定,纯化后的壳聚糖酶活力可达10163.826U/mg。
实施例6 测定重组壳聚糖酶的最适反应条件
反应条件为:选取35℃、40℃、45℃、50℃、55℃、60℃、65℃、70℃反应15min测定最适温度;在50℃下,选用pH为3.0~10.0的缓冲液作为酶反应的不同测定pH缓冲液,根据壳聚糖酶的酶活力,确定壳聚糖酶的最适pH。结果如图2,图3所示,重组壳聚糖酶的最适反应温度为50℃,最适pH为8。
实施例7 测定重组壳聚糖酶的降解产物
将实施例4中纯化所得壳聚糖酶Csn-PT与2%的胶体壳聚糖在50℃下分别孵育不同时间,然后用TLC板检测产物。具体为:展开剂(正丙醇:氨水=2:10),显色剂(0.5%茚三酮乙醇溶液)110℃显色。如图4所示,壳聚糖酶Csn-PT酶解产物为壳单糖(DP1)到壳六糖(DP6)。
实施例8 利用重组壳聚糖酶制备酶制剂
利用实施例4制备的重组壳聚糖酶制备酶制剂:发酵破碎后的溶液纯化后,用缓冲液置换咪唑,冻干后保存酶粉。
给本领域技术人员提供上述实施例,以完全公开和描述如何实施和使用所主张的实施方案,而不是用于限制本文公开的范围。对于本领域技术人员而言显而易见的修饰将在所附权利要求的范围内。
序列表
<110> 中国海洋大学
<120> 壳聚糖酶Csn-PT及其应用
<141> 2020-06-02
<160> 4
<170> SIPOSequenceListing 1.0
<210> 1
<211> 299
<212> PRT
<213> Artificial Sequence
<400> 1
Met Ser Asn Ala Arg Pro Ser Lys Ser Gln Thr Lys Phe Leu Leu Ala
1 5 10 15
Phe Leu Cys Phe Thr Leu Val Ala Ser Leu Phe Gly Ala Thr Ala Leu
20 25 30
Phe Gln Pro Ser Lys Ala Ala Ala Ala Ser Pro Asp Asp Asn Phe Ser
35 40 45
Pro Glu Thr Leu Gln Phe Leu Arg Asn Asn Thr Gly Leu Asp Gly Glu
50 55 60
Gln Trp Asn Asn Ile Met Lys Leu Ile Asn Lys Pro Glu Gln Asp Asp
65 70 75 80
Leu Asn Trp Ile Glu Tyr Tyr Gly Tyr Cys Glu Asp Ile Thr Asp Glu
85 90 95
Arg Gly Tyr Thr Ile Gly Leu Phe Gly Ala Thr Thr Gly Gly Ser Arg
100 105 110
Asp Thr His Pro Asp Gly Pro Glu Leu Phe Lys Ala Tyr Asp Ala Ala
115 120 125
Lys Gly Ala Ser Asn Pro Ser Ala Asp Gly Ala Leu Lys Arg Leu Gly
130 135 140
Ile Asn Gly Lys Met Asn Gly Ser Ile Leu Glu Ile Lys Asp Ser Glu
145 150 155 160
Lys Val Phe Cys Gly Lys Ile Lys Lys Leu Gln Asn Asp Ala Ala Trp
165 170 175
Arg Lys Ala Met Trp Glu Thr Phe Tyr Asn Val Tyr Ile Arg Tyr Ser
180 185 190
Val Glu Gln Ala Arg Gln Arg Gly Phe Ala Ser Ala Val Thr Ile Gly
195 200 205
Ser Phe Val Asp Thr Ala Leu Asn Gln Gly Ala Thr Gly Gly Ser Asn
210 215 220
Thr Leu Gln Gly Leu Leu Ala Arg Ser Gly Ser Ser Ser Asn Glu Lys
225 230 235 240
Thr Phe Met Lys Asn Phe His Ala Lys Arg Thr Leu Val Val Asp Thr
245 250 255
Asn Lys Tyr Asn Lys Pro Pro Asn Gly Lys Asn Arg Val Lys Gln Trp
260 265 270
Asp Thr Leu Val Asp Met Gly Lys Met Asn Leu Lys Asn Val Asp Ser
275 280 285
Glu Ile Ala Lys Val Thr Asp Trp Glu Met Lys
290 295
<210> 2
<211> 897
<212> DNA
<213> Artificial Sequence
<400> 2
atgagcaatg cccgcccgag caaaagccag accaaatttc tgctggcctt tctgtgtttt 60
accctggtgg ccagcctgtt tggcgcaacc gccctgtttc agccgagtaa agcagcagca 120
gcaagcccgg atgataattt tagtccggaa accctgcagt ttctgcgtaa taataccggt 180
ctggatggcg aacagtggaa taatattatg aaactgatca acaagccgga acaggatgat 240
ctgaattgga ttgaatatta tggctattgc gaagatatca ccgatgaacg tggctatacc 300
attggtctgt ttggtgcaac caccggcggc agccgtgata cccatccgga tggtccggaa 360
ctgtttaaag catacgatgc agccaaaggt gccagcaatc cgagcgccga tggtgccctg 420
aaacgcctgg gtattaatgg taaaatgaat ggcagcattc tggaaattaa ggatagcgaa 480
aaagttttct gtggcaaaat taagaagctg cagaatgatg cagcctggcg taaagcaatg 540
tgggaaacct tttataatgt ttatatccgc tacagcgttg aacaggcacg ccagcgcggt 600
tttgcaagcg ccgtgaccat tggtagtttt gttgataccg ccctgaatca gggcgccacc 660
ggtggcagta ataccctgca gggtctgctg gcccgcagcg gtagcagtag taatgaaaaa 720
acctttatga agaacttcca cgccaaacgt accctggtgg ttgataccaa taagtataat 780
aagccgccga atggtaaaaa tcgcgttaaa cagtgggata ccctggttga tatgggtaaa 840
atgaacctga aaaatgttga tagtgagatt gcaaaagtga ccgattggga aatgaaa 897
<210> 3
<211> 40
<212> DNA
<213> Artificial Sequence
<400> 3
cgagtgcggc cgcaagcttt ttcatttccc aatcggtcac 40
<210> 4
<211> 33
<212> DNA
<213> Artificial Sequence
<400> 4
caaatgggtc gcggatcctg agcaatgccc gcc 33
Claims (1)
1.一种降解壳聚糖制备GlcN-(GlcN)6的方法,其特征在于:采用氨基酸序列如SEQ IDNO.1所示的壳聚糖酶Csn-PT降解壳聚糖,酶解主要产物为壳单糖到壳三糖,降解条件为:温度50℃,pH 8。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202010491045.9A CN111471667B (zh) | 2020-06-02 | 2020-06-02 | 壳聚糖酶Csn-PT及其应用 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202010491045.9A CN111471667B (zh) | 2020-06-02 | 2020-06-02 | 壳聚糖酶Csn-PT及其应用 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN111471667A CN111471667A (zh) | 2020-07-31 |
CN111471667B true CN111471667B (zh) | 2022-03-22 |
Family
ID=71765117
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202010491045.9A Active CN111471667B (zh) | 2020-06-02 | 2020-06-02 | 壳聚糖酶Csn-PT及其应用 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN111471667B (zh) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN118165959B (zh) * | 2024-05-14 | 2024-07-19 | 中国海洋大学 | 壳聚糖酶OUC-CsnA4-E59V及其编码基因与应用 |
-
2020
- 2020-06-02 CN CN202010491045.9A patent/CN111471667B/zh active Active
Also Published As
Publication number | Publication date |
---|---|
CN111471667A (zh) | 2020-07-31 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN111344399B (zh) | 一种udp-葡萄糖基转移酶突变体、其应用及其制备莱鲍迪苷d的方法 | |
CN108330119B (zh) | 一种壳聚糖酶及其在壳寡糖制备中的应用 | |
CN112708609B (zh) | 壳聚糖酶OUC-CsnPa及其应用 | |
CN114410611B (zh) | 昆布多糖降解酶OUC-BsLam26及其应用 | |
CN111944865B (zh) | 一种细菌来源的α-L-鼠李糖苷酶在高效生产橙皮素-7-O-葡萄糖苷中的应用 | |
CN112725319B (zh) | polyG底物特异性的褐藻胶裂解酶FaAly7及其应用 | |
CN113980937B (zh) | λ-卡拉胶酶OUC-G150-L7及其应用 | |
CN110511917B (zh) | 一种脱乙酰酶及其编码基因与应用 | |
CN111088183B (zh) | 一种海洋弧菌及其在制备热稳定特性的ι-卡拉胶酶中的应用 | |
CN113736763A (zh) | 黑芥子酶Rmyr及其在制备萝卜硫素、莱菔素中的应用 | |
CN112899177A (zh) | 表达黑芥子酶tgg4的重组解脂耶氏酵母菌及其应用 | |
CN110423787B (zh) | 一种均一性褐藻三糖的制备方法 | |
CN111471667B (zh) | 壳聚糖酶Csn-PT及其应用 | |
CN111334488B (zh) | 昆布多糖酶ouc-l1及其编码基因与应用 | |
CN112980815A (zh) | α-L-岩藻糖苷酶OUCJdch-16及其应用 | |
CN111187764B (zh) | 一种深海来源的壳聚糖酶csn5及其编码基因和应用 | |
CN109609485B (zh) | 一种甲壳素脱乙酰酶及其应用 | |
CN114958933B (zh) | 一种利用黑芥子酶Emyr制备莱菔素的方法 | |
CN111041013A (zh) | 一种褐藻胶裂解酶或果胶酶及其在协同降解褐藻方面的应用 | |
CN113512544B (zh) | 一种热稳定性提高的甘露糖异构酶突变体 | |
CN107236772B (zh) | 一种制备褐藻寡糖的方法 | |
CN111549007B (zh) | 一种转氨酶tsta、制备方法和应用 | |
CN114196655A (zh) | 耐热性昆布多糖降解酶OUC-SaLam66及其应用 | |
CN110144340B (zh) | 一种壳聚糖酶CsnQ及其应用 | |
CN111849949B (zh) | 一种甘露糖醛酸c-5差向异构酶/海藻酸裂解酶编码基因及酶和制备与应用 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant |